PHARMACY

Nasdaq notifies EpiCept of lack of listing compliance

BY Drew Buono

Tarrytown, N.Y. Nasdaq has notified the pain and cancer treatment company EpiCept that it is not in compliance with requirements to be listed on the Nasdaq Capital Market because the market value of the company’s listed securities has fallen below $35 million for 10 consecutive trading days.

EpiCept will now be given until May 5 to regain compliance. If the company does not, it will have the right to appeal a determination to delist its securities. During that appeal process, EpiCept would remain on the market, and the company said in a statement that it intends to focus its efforts on regaining compliance

The company’s portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound is approaching a decision in Europe, according to the company.

In addition, the company stated, its ASAP technology, a proprietary live cell high-throughput caspase-3 screening technology, can efficiently identify new cancer drug candidates and molecular targets that selectively induce apoptosis in cancer cells.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Teva pays $7.5 million to settle IVAX lawsuit with Depomed

BY Drew Buono

MENLO PARK, Calif. Depomed will receive a one-time payment of $7.5 million from Teva Pharmaceuticals generic unit IVAX in relation to a settlement of a patent lawsuit, according to published reports.

Depomed had sued IVAX in January 2006 claiming patent infringement by IVAX’s Glucophage XR, a diabetes medication.

Under the terms of the settlement, Depomed will also get up to $2.5 million in royalties, for granting Teva a non-exclusive license allowing it to continue marketing the generic version of Glucophage XR.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

SynaMed launches free online PHR

BY Drew Buono

NEW YORK SynaMed has launched its free online personal health record, which will be available to all patients.

“SynaMed simplifies record keeping so that patients do not have to rely on memory. A personal health record can also provide lifesaving medical information when a patient is not able to speak for themselves,” according to Holly DeMuro, SynaMed’s director of operations. SynaMed’s personal health record system uses a Web browser-based application service provider model, which allows patients access anytime, from anywhere with Internet connection.

Patients using SynaMed’s personal health record will be able to record all of their medical history, doctor’s visits, check insurance coverage for medications, and receive health maintenance reminders about wellness issues and checkups. “Going forward, SynaMed will be expanding the Personal Health Record to include overall health information such as mood, weight, diet, and exercise trackers. This feature will be the first complete online wellness center,” DeMuro said.

In addition to a state of the art PHR, SynaMed offers a free fully integrated electronic medical record and practice management system to medical practitioners.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES